These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26410289)

  • 41. Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.
    Sosnay PR; Raraigh KS; Gibson RL
    Pediatr Clin North Am; 2016 Aug; 63(4):585-98. PubMed ID: 27469177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers.
    Pizurki L; Morris MA; Chanson M; Solomon M; Pavirani A; Bouchardy I; Suter S
    Am J Pathol; 2000 Apr; 156(4):1407-16. PubMed ID: 10751364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholangiocyte biology and cystic fibrosis liver disease.
    Feranchak AP; Sokol RJ
    Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demographics of the UK cystic fibrosis population: implications for neonatal screening.
    McCormick J; Green MW; Mehta G; Culross F; Mehta A
    Eur J Hum Genet; 2002 Oct; 10(10):583-90. PubMed ID: 12357328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.
    Stalvey MS; Muller C; Schatz DA; Wasserfall CH; Campbell-Thompson ML; Theriaque DW; Flotte TR; Atkinson MA
    Diabetes; 2006 Jul; 55(7):1939-45. PubMed ID: 16804061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CFTR modulator therapy improves cystic fibrosis-related diabetes. But how?
    Bojanowski CM; Wilson SM; Klingsberg RC
    J Diabetes Complications; 2021 Jun; 35(6):107887. PubMed ID: 33775536
    [No Abstract]   [Full Text] [Related]  

  • 48. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
    Solomon GM; Marshall SG; Ramsey BW; Rowe SM
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40(0 40):S3-S13. PubMed ID: 26097168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
    Alibakhshi R; Zamani M
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
    Kerem E; Rave-Harel N; Augarten A; Madgar I; Nissim-Rafinia M; Yahav Y; Goshen R; Bentur L; Rivlin J; Aviram M; Genem A; Chiba-Falek O; Kraemer MR; Simon A; Branski D; Kerem B
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1914-20. PubMed ID: 9196095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid progression to diabetes in a four-year-old girl with cystic fibrosis.
    Pirgon O; Cekmez F; Eren E
    Br J Biomed Sci; 2012; 69(1):39-41. PubMed ID: 22558806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
    Pettit RS
    Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biosynthesis of cystic fibrosis transmembrane conductance regulator.
    Pranke IM; Sermet-Gaudelus I
    Int J Biochem Cell Biol; 2014 Jul; 52():26-38. PubMed ID: 24685677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CFTR: cystic fibrosis and beyond.
    Mall MA; Hartl D
    Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Question 4. What diagnostic and therapeutic strategies in glucose metabolism disorders in cystic fibrosis? Therapeutic strategy in glucose metabolism disorders on cystic fibrosis].
    Martin C
    Arch Pediatr; 2003 Aug; 10 Suppl 3():469s-474s. PubMed ID: 14671962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.